Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/27/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Stephen P. Squinto

Wrong Dr. Stephen P. Squinto?

Executive Vice President, Chief G...

Alexion Pharmaceuticals Inc
352 Knotter Drive
Cheshire , Connecticut 06511
United States

Company Description: Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and delivery of biologic therapeutic products for the...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D.
  • doctorate degree , biochemistry and biophysics
    Loyola University
  • bachelor's degree , chemistry
    Loyola University
  • Ph.D. , Company
  • PhD
  • B.A. , Chemistry
    Loyola University of Chicago
138 Total References
Web References
Health Industry Updates
www.leadershipdirectories.com, 16 Feb 2015 [cached]
Alexion Pharmaceuticals, Inc. announced that Stephen Squinto, PhD, will retire from the company, effective January 1, 2015. He will continue to serve the company as Chair of its newly formed Scientific Advisory Board.
Stephen Squinto, Ph.D., ...
alexionpharma.com, 17 Dec 2014 [cached]
Stephen Squinto, Ph.D., Executive Vice President, Chief Global Operations Officer
Stephen Squinto, Ph.D. is co-founder of Alexion Pharmaceuticals and currently serves as Executive Vice President and Chief Global Operations Officer. Dr. Squinto is responsible for Alexion's Global Quality, Manufacturing and Project Management functions.
Since co-founding Alexion with CEO Leonard Bell in 1992, Dr. Squinto has held several leadership positions guiding the company's research and development programs across the Alexion pipeline, including Executive Vice President, Head of R&D, during which he led the Company's program that resulted in Soliris ® approvals for patients with atypical hemolytic uremic syndrome in the US, European Union and Japan.
Prior to co-founding Alexion, Dr. Squinto held various scientific positions at Regeneron Pharmaceuticals, Inc., focused on drug discovery. He has also served as Assistant Professor of Biochemistry and Molecular Biology at Louisiana State University Medical Center. Dr. Squinto is a prominent researcher in molecular and cellular biology, with more than 70 scientific papers resulting from his work. He also serves on the Board of Directors of the regional Chapter of the Juvenile Diabetes Research Foundation.
Dr. Squinto received a bachelor's degree in chemistry and a doctorate degree in biochemistry and biophysics from Loyola University in Chicago.
Alexion Pharmaceuticals - Management Team
www.alxn.com, 5 July 2013 [cached]
Stephen Squinto, Ph.D. Executive Vice President, Chief Global Operations Officer
...
Stephen Squinto, - Executive Vice President, Chief Global Operations Officer
Stephen Squinto, Ph.D. is co-founder of Alexion Pharmaceuticals and currently serves as Executive Vice President and Chief Global Operations Officer. Dr. Squinto is responsible for Alexion's Global Quality, Manufacturing and Project Management functions.
Since co-founding Alexion with CEO Leonard Bell in 1992, Dr. Squinto has held several leadership positions guiding the company's research and development programs across the Alexion pipeline, including Executive Vice President, Head of R&D, during which he led the Company's program that resulted in Soliris ® approvals for patients with atypical hemolytic uremic syndrome in the US, European Union and Japan.
Prior to co-founding Alexion, Dr. Squinto held various scientific positions at Regeneron Pharmaceuticals, Inc., focused on drug discovery. He has also served as Assistant Professor of Biochemistry and Molecular Biology at Louisiana State University Medical Center. Dr. Squinto is a prominent researcher in molecular and cellular biology, with more than 70 scientific papers resulting from his work. He also serves on the Board of Directors of the regional Chapter of the Juvenile Diabetes Research Foundation.
Dr. Squinto received a bachelor's degree in chemistry and a doctorate degree in biochemistry and biophysics from Loyola University in Chicago.
American College of Lifestyle ...
www.prweb.com, 28 Jan 2015 [cached]
American College of Lifestyle Medicine President David Katz Welcomes Stephen Squinto as First Benefactor of the GLiMMER Project and True Health Coalition
...
David Katz, MD, MPH, president of the American College of Lifestyle Medicine, welcomes Stephen Squinto, PhD, Alexion Pharmaceuticals, Inc. co-founder and former chief global operations officer, as first major benefactor of the GLiMMER Project and its True Health Coalition.
...
Dr. Squinto has made significant contributions to public health. I greatly appreciate his generosity and commitment to this project and am thrilled that the GLiMMER initiative is officially under way.
Nashville, TN (PRWEB) January 28, 2015
David Katz, MD, MPH, president of the American College of Lifestyle Medicine (ACLM) and founding director of the Yale University's Prevention Research Center today announced the major backing of the GLiMMER Project (Global Lifestyle Medicine Movement to Effect Revolution) and its True Health Coalition by Stephen Squinto, PhD, recently retired Alexion co-founder.
...
In the wake of his January 1 retirement from Alexion, Squinto was in search of a meaningful project behind which he could throw his support. He was intrigued when learning about plans for the GLiMMER Project and the True Health Coalition, seeing the void in the world for the convening by widely respected leaders of global renown, speaking with one voice to establish universal knowledge of the common core elements of lifestyle as medicine and their capacity to create a blueprint to rein in our ever escalating chronic disease trends and the associated costs.
"It's imperative that we take immediate and decisive action to address the alarming reality of our current health crisis," said Squinto. "I've devoted my career to the pharmaceutical industry but certainly understand the power of lifestyle medicine in light of the fact that 80% or more of our healthcare costs are directly tied to poor lifestyle choices."
Squinto was quick to note his high regard for the leadership of David Katz, adding "In order for a project of this magnitude to succeed, it needs to be in the hands of capable people.
...
"Dr. Squinto has made significant contributions to public health of his own," said Katz.
Board of Directors and Chapter History | Greater New Haven Chapter
gnh.jdrf.org, 17 Aug 2014 [cached]
Stephen Squinto,Alexion Pharmaceuticals
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304